An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer

por Cheng, Shao-Xian, Chen, Qiu-Chi, Lin, Guo-He, Han, Yan-Hong, Wang, Bi-Cheng, Dai, Yi, Zhao, Yan-Xia
Publicado 2023